Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID R
An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.
| Condition(s) | Autoimmune Diseases, Autoinflammatory Diseases |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases. |
| Who can participate | Inclusion Criteria: * Age \<= 18 years old * Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity) * Diagnosed and Treated in China Exclusion Criteria: * Disagreement of involving in this study by the patient or his/her family. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Peking Union Medical College Hospital |
| Locations | Beijing, Beijing Municipality, China; Beijing, Beijing Municipality, China; Beijing, Beijing Municipality, China; Chongqing, Chongqing Municipality, China; Shenzhen, Guangdong, China; Shenzhen, Guangdong, China (+3 more sites) |
| Start date | 2022-04-29 |
| NCT ID | NCT06417502 |
| Official listing | https://clinicaltrials.gov/study/NCT06417502 |